Unknown

Dataset Information

0

Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.

ABSTRACT:

SUBMITTER: Peng W 

PROVIDER: S-EPMC10917457 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.

Peng Wei W   Wu Youwei Y   Zhang Xiaoyun X   Li Chuan C   Shen Junyi J   Chen Weixia W   Li Qiu Q   Ma Ji J   Yang Yu Y   Lu Wusheng W   Liu Zuojin Z   Sun Xin X   Yang Jiayin J   Zhou Yongjie Y   Wen Tianfu T  

The British journal of surgery 20240301 3

Similar Datasets

Unknown Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study.
| S-EPMC9511022 | biostudies-literature
Unknown Preclinical Therapeutic Evaluation of Lenvatinib-Eluting Microspheres for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
| S-EPMC10578029 | biostudies-literature
Unknown Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma.
| S-EPMC9776720 | biostudies-literature
Unknown Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study.
| S-EPMC11464841 | biostudies-literature
Unknown Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy.
| S-EPMC8716800 | biostudies-literature
Unknown Preliminary experience of lenvatinib, tislelizumab and transcatheter arterial chemoembolization for BCLC stage C hepatocellular carcinoma: a phase II study.
| S-EPMC12541939 | biostudies-literature
Unknown Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.
| S-EPMC8502053 | biostudies-literature
Unknown Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study.
| S-EPMC10758712 | biostudies-literature
Unknown Lenvatinib in combination with radiotherapy versus lenvatinib with transarterial chemoembolization for advanced hepatocellular carcinoma.
| S-EPMC12482564 | biostudies-literature
Unknown Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.
| S-EPMC5470590 | biostudies-literature